Peptislim faced the toughest regulatory environment we’ve encountered. A ground-up
compliance overhaul, creative reinvention, and a focused Meta ads strategy scaled the brand
faster than any client before it.
Peptislim is an Australian research peptide brand targeting a market governed by some of the most
rigorous advertising and compliance standards in the world. The TGA framework and Meta’s regional
enforcement made every step of this engagement more demanding than a standard compliance case.
The Problem
Peptislim arrived with the same pattern — but in Australia, the stakes were higher. Stricter standards
meant content acceptable elsewhere was flagged, and the margin for error on creatives was razor thin.
Product descriptions and blog content contained human-use language violating Australian TGA standards — stricter than US or UK equivalents.
Meta's Australian policy team flagged the account for health product violations, blocking all campaign delivery.
The biggest challenge. AU Meta enforcement rejected imagery and copy that passes in other markets — requiring multiple full redesigns.
Accumulated violations led to a full account suspension, ending all paid acquisition.
Our Approach
We ran a comprehensive audit of every page — product listings, descriptions, blogs, FAQs and reviews —
mapped against TGA advertising guidelines. The scope was broader and stricter than any previous
engagement.
All product descriptions were stripped back and rewritten from scratch — short, precise, research-use only.
No health benefit language, no outcome framing, no implied human use. Say less, mean more
The most challenging phase. Our design team went through multiple full creative iterations — visuals,
copy, and structure — testing each against Meta's Australian policy framework. We built a strict internal
pre-clearance process specifically for AU health product creatives.
With a compliant site and cleared creatives, we launched a Meta campaign strategy tailored for Australian
research audiences. Campaigns were monitored daily in early weeks to catch any policy signals before
they escalated.
Outcomes
When BodyLab came to us, their entire digital operation was stalled. Non-compliant content had triggered a cascade of platform penalties that made running ads — and growing the brand — nearly impossible.
If you’re running a research peptide brand and struggling with ad disapprovals, scaling limitations, or compliance uncertainty — let’s fix it.
